Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Haemonetics Corporation
With
Machaon Diagnostics
ClinStatDevice
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Adult volunteers (18 years of age and older) who self-identify as being in general good health.
You may not be if
Volunteers with any acute illness or uncontrolled chronic disease
Volunteers with any type of cancer
Volunteers with diabetes
Volunteers with renal disease
Volunteers with liver disease
Volunteers with morbid obesity
Volunteers with autoimmune or inflammatory diseases
Volunteers with known coagulation and/or bleeding disorders (e.g., hemophilia, Von Willebrand's disease)
Volunteers currently abusing alcohol (defined as more than 3 drinks for women and more than 4 drinks for men on any given day, or 7 drinks for women and 14 drinks for men throughout the week) or taking illicit drugs
Volunteers with hereditary fibrinolytic bleeding disorders
Volunteers with altered coagulation due to the presence of direct oral anticoagulants (e.g., apixaban, rivaroxaban, dabigatran) in the blood
Volunteers on any fibrinolytic activators (e.g., Streptokinase, t-PA, Reteplase, Tenecteplase, Urokinase, APSAC, Staphylokinase)
Volunteers who have had recent surgery (within the last four weeks)
Volunteers with any injuries leading to substantial bleeding or bruising (within the last two weeks prior to blood donation)
Volunteers with bruising, wounds, or scarring around the selected venipuncture site
Volunteers deemed unfit for participation in the trial by the principal investigator
Volunteers participating in another clinical trial that would not be scientifically or medically compatible with this trial
Volunteers who have been on P2Y12 inhibitors within the last 30 days
Volunteers receiving treatment with low molecular weight heparin (e.g., enoxaparin)
Volunteers with altered coagulation due to the presence of drugs known to affect the coagulation status in the blood (see Table 1)
Volunteers who have participated in this trial previously
Clareo Health | Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers
